Link Pharma Chem Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 8.02 | 6.56 | 4.78 |
Operating Expense | 7.17 | 6.67 | 5.23 |
Net Profit | 0.40 | -0.35 | -0.67 |
Net Profit Margin | 4.99 | -5.34 | -14.02 |
Earning Per Share | 0.91 | -0.79 | -1.50 |
EBIDTA | 0.74 | 0.06 | -0.22 |
Effective Tax Rate | TBA | -27.27 | TBA |
Particulars | Jun 2025 |
---|---|
Revenue | 8.02 |
Operating Expense | 7.17 |
Net Profit | 0.40 |
Net Profit Margin | 4.99 |
Earning Per Share | 0.91 |
EBIDTA | 0.74 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 25.43 | 29.90 | 38.76 |
Operating Expenses Annual | 25.30 | 30.55 | 36.04 |
Operating Profit Annual | 0.32 | -0.01 | 2.57 |
Interest Annual | 0.78 | 0.87 | 0.76 |
Depreciation | 0.94 | 1.03 | 0.92 |
Net Profit Annual | -1.03 | -1.36 | 0.65 |
Tax Annual | -0.38 | -0.55 | 0.23 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 25.43 |
Operating Expenses Annual | 25.30 |
Operating Profit Annual | 0.32 |
Interest Annual | 0.78 |
Depreciation | 0.94 |
Net Profit Annual | -1.03 |
Tax Annual | -0.38 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.06 | 0.09 | 0.27 |
Cash Flow from Operations | 2.69 | -0.03 | -1.71 |
Cash Flow from Investing | 1.53 | 0.41 | -0.08 |
Cash Flow from Financing | -4.21 | -0.41 | 1.61 |
Cash Flow at the End | 0.06 | 0.06 | 0.09 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.06 |
Cash Flow from Operations | 2.69 |
Cash Flow from Investing | 1.53 |
Cash Flow from Financing | -4.21 |
Cash Flow at the End | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 1.26 | -0.03 | 6.24 |
PBIT Margin (%) | -2.44 | -3.48 | 3.87 |
PBT Margin (%) | 0.75 | 0.53 | -1.19 |
Net PROFIT Margin (%) | -4.05 | -4.55 | 1.68 |
Return On Networth / Equity (%) | -7.81 | -9.46 | 3.86 |
Return On Networth /Employed (%) | -3.03 | -4.43 | 6.64 |
Return On Assets (%) | -4.94 | -5.78 | 2.90 |
Total Debt / Equity (X) | 0.57 | 0.63 | 0.51 |
Asset Turnover Ratio (%) | 1.22 | 1.27 | 1.73 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 1.26 |
PBIT Margin (%) | -2.44 |
PBT Margin (%) | 0.75 |
Net PROFIT Margin (%) | -4.05 |
Return On Networth / Equity (%) | -7.81 |
Return On Networth /Employed (%) | -3.03 |
Return On Assets (%) | -4.94 |
Total Debt / Equity (X) | 0.57 |
Asset Turnover Ratio (%) | 1.22 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 9.28 | 9.94 | 9.00 |
Total Current Assets Annual | 11.16 | 11.53 | 17.55 |
Non Current Assets Annual | 12.13 | 14.42 | 14.91 |
Total Shareholders Funds Annual | 12.66 | 13.71 | 15.04 |
Total Assets Annual | 23.29 | 25.95 | 32.46 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 9.28 |
Total Current Assets Annual | 11.16 |
Non Current Assets Annual | 12.13 |
Total Shareholders Funds Annual | 12.66 |
Total Assets Annual | 23.29 |
No Data Availabe